Bastide announced the acquisition of TCM Pharma (€4m of sales) located in the Paris region, specialised in the set-up and the follow-up of drip nutrition devices for patients at home. TCM Pharma’s current CEO will step down but will remain committed to the company’s development and the company’s integration (TCM to be consolidated from 1 January 2017). The acquisition is financed by a mix of cash and debt.
01 Feb 2017
Bastide strikes a fifth acquisition within a month
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Bastide strikes a fifth acquisition within a month
Bastide Le Confort Medical SA (0IP1:LON) | 0 0 (-0.6%) | Mkt Cap: 371.4m
- Published:
01 Feb 2017 -
Author:
Bérénice Lacroix -
Pages:
2
Bastide announced the acquisition of TCM Pharma (€4m of sales) located in the Paris region, specialised in the set-up and the follow-up of drip nutrition devices for patients at home. TCM Pharma’s current CEO will step down but will remain committed to the company’s development and the company’s integration (TCM to be consolidated from 1 January 2017). The acquisition is financed by a mix of cash and debt.